Mechanical blood trauma in circulatory-assist devices /

Saved in:
Bibliographic Details
Author / Creator:Maul, Timothy M. (Timothy Michael), author.
Imprint:New York : ASME Press, [2015]
Description:1 online resource (50 pages)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12016085
Hidden Bibliographic Details
ISBN:9781336097476
1336097477
9781606507841
1606507842
9780791860397
0791860396
Notes:Print version record.
Summary:Mechanical cardiovascular assist devices must be properly designed to avoid damage to the blood they contact. The factors that affect the hemocompatibility of a cardiovascular assist device include three major non-physiological components - the material, fluid flow paths, and flow related stresses - as well as the device interaction with the native vasculature. Furthermore, the interaction of the device with the blood is not static. Foreign surfaces activate blood components including platelets, leukocytes and the coagulation cascade. Thrombus formation on the surface of the device can alter the fluid dynamics in a manner that causes erythrocyte damage ranging from significant hemolysis to sub-lethal trauma that can take many days to weeks to develop into a significant clinical problem. This sub-lethal blood trauma is not easily detectable without special equipment, which is typically unavailable in routine clinical practice. Surveillance for blood damage is often suboptimal in the clinical setting, but once clinically relevant hemolysis occurs, crucial decisions - device removal, replacement, or additional medical therapies including surgery or plasmapheresis - that take into account the risk/benefit of intervention must be quickly evaluated. The various pre-clinical designs and testing, surgical considerations, available surveillance techniques, and clinical consequences will be discussed using recent and historical case reports to highlight key points.

MARC

LEADER 00000cam a2200000Mi 4500
001 12016085
006 m o d
007 cr |n|||||||||
008 150306s2015 nyu o 000 0 eng d
005 20240628154842.0
020 |a 9781336097476  |q (electronic bk.) 
020 |a 1336097477  |q (electronic bk.) 
020 |a 9781606507841  |q (electronic bk.) 
020 |a 1606507842  |q (electronic bk.) 
020 |z 9780791860397 
020 |z 0791860396 
035 |a (OCoLC)904424827 
035 9 |a (OCLCCM-CC)904424827 
037 |a 741033  |b MIL 
040 |a IDEBK  |b eng  |e pn  |c IDEBK  |d NYMPP  |d OCLCO  |d E7B  |d EBLCP  |d OCLCF  |d N$T  |d UIU  |d OCLCQ  |d MERER  |d OCLCQ  |d INT  |d OCLCQ  |d K6U 
049 |a MAIN 
050 4 |a RC685.C53  |b M285 2015 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
100 1 |a Maul, Timothy M.  |q (Timothy Michael),  |e author.  |0 http://id.loc.gov/authorities/names/n2015182404 
245 1 0 |a Mechanical blood trauma in circulatory-assist devices /  |c Timothy M. Maul, Department od Cardiothoracic Surgery, University of Pittburgh School of Medicine, Pittsburgh, PA, McGowan Insititue for Regenerative Medicin, University of Pittsburg, Pittsburgh, PA, Department of Biomedical Engineering, University of Pittsburg, Pittsburgh, PA, Marina V. Kameneva, McGowan Insititue for Regenerative Medicin, University of Pittsburg, Pittsburgh, PA, Department of Biomedical Engineering, University of Pittsburg, Pittsburgh, PA, Peter D. Wearden, Department od Cardiothoracic Surgery, University of Pittburgh School of Medicine, Pittsburgh, PA, McGowan Insititue for Regenerative Medicin, University of Pittsburg, Pittsburgh, PA. 
264 1 |a New York :  |b ASME Press,  |c [2015] 
300 |a 1 online resource (50 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a 1. Introduction. 
505 8 |a 2. Hemolysis. 
505 8 |a 3. Testing blood trauma in circulatory assist devices -- 3.1 Historical overview -- 3.2 Mechanical stresses which produce high levels of hemolysis. 
505 8 |a 4. Sublethal blood trauma -- 4.1 Effect of mechanical stress on RBC deformability -- 4.2 Effect of mechanical stress on RBC aggregation -- 4.3 Mechanical fragility of red blood cells. 
505 8 |a 5. Damage to leukocytes -- 5.1 Thrombosis and bleeding -- 5.1.1 In vitro studies of the mechanical stress effects on platelets. 
505 8 |a 6. In vitro testing devices for blood biocompatibility -- 6.1 Methods of plasma free Hb measurement -- 6.1.1 OxyHb absorbency at 540 nm -- 6.1.2 Cripps method -- 6.2 Normalized Index of Hemolysis. 
505 8 |a 7. Clinical issues and experience -- 7.1 Sequelae from hemolysis -- 7.2 Hemoglobin-haptoglobin complex -- 7.3 Effect of free Hb on platelets -- 7.4 Historical review of devices and resultant hemolysis issues -- 7.5 Surgical approaches to limit hemolysis. 
505 8 |a 8. Medical therapy elevated plasma free hemoglobin. 
505 8 |a 9. Concluding remarks. 
505 8 |a 10. References. 
520 3 |a Mechanical cardiovascular assist devices must be properly designed to avoid damage to the blood they contact. The factors that affect the hemocompatibility of a cardiovascular assist device include three major non-physiological components - the material, fluid flow paths, and flow related stresses - as well as the device interaction with the native vasculature. Furthermore, the interaction of the device with the blood is not static. Foreign surfaces activate blood components including platelets, leukocytes and the coagulation cascade. Thrombus formation on the surface of the device can alter the fluid dynamics in a manner that causes erythrocyte damage ranging from significant hemolysis to sub-lethal trauma that can take many days to weeks to develop into a significant clinical problem. This sub-lethal blood trauma is not easily detectable without special equipment, which is typically unavailable in routine clinical practice. Surveillance for blood damage is often suboptimal in the clinical setting, but once clinically relevant hemolysis occurs, crucial decisions - device removal, replacement, or additional medical therapies including surgery or plasmapheresis - that take into account the risk/benefit of intervention must be quickly evaluated. The various pre-clinical designs and testing, surgical considerations, available surveillance techniques, and clinical consequences will be discussed using recent and historical case reports to highlight key points. 
650 0 |a Congestive heart failure  |x Treatment. 
650 0 |a Blood  |x Circulation, Artificial.  |0 http://id.loc.gov/authorities/subjects/sh85014933 
650 0 |a Cardiovascular instruments, Implanted.  |0 http://id.loc.gov/authorities/subjects/sh85020225 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Blood  |x Circulation, Artificial.  |2 fast  |0 (OCoLC)fst00834566 
650 7 |a Cardiovascular instruments, Implanted.  |2 fast  |0 (OCoLC)fst00847169 
650 7 |a Congestive heart failure  |x Treatment.  |2 fast  |0 (OCoLC)fst00875132 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
903 |a HeVa 
929 |a oclccm 
999 f f |i e7331a12-db56-54ed-8223-1133d1a4d8bc  |s 54f4bd09-5f39-5764-beb9-0d4f269a71c0 
928 |t Library of Congress classification  |a RC685.C53 M285 2015  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=960936  |z eBooks on EBSCOhost  |g ebooks  |i 12423810